136 related articles for article (PubMed ID: 7544135)
1. Inhibition of the angiotensin converting enzyme by perindoprilat and release of nitric oxide.
Desta B; Vanhoutte PM; Boulanger CM
Am J Hypertens; 1995 May; 8(5 Pt 2):1S-6S. PubMed ID: 7544135
[TBL] [Abstract][Full Text] [Related]
2. Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.
Desta B; Nakashima M; Kirchengast M; Vanhoutte PM; Boulanger CM
J Pharmacol Exp Ther; 1995 Feb; 272(2):885-91. PubMed ID: 7531766
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
[TBL] [Abstract][Full Text] [Related]
4. Kininase-independent potentiation of endothelium-dependent relaxations to kinins by converting enzyme inhibitor perindoprilat.
Mombouli JV; Ballard KD; Vanhoutte PM
Acta Pharmacol Sin; 2002 Mar; 23(3):203-7. PubMed ID: 11918842
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training.
Mombouli JV; Nakashima M; Hamra M; Vanhoutte PM
Br J Pharmacol; 1996 Feb; 117(3):413-418. PubMed ID: 8821528
[TBL] [Abstract][Full Text] [Related]
6. Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels.
Kerth PA; Vanhoutte PM
Am J Hypertens; 1991 Mar; 4(3 Pt 2):226S-234S. PubMed ID: 2043312
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibition enhances bradykinin relaxations through nitric oxide and B1 receptor activation in bovine coronary arteries.
Gauthier KM; Cepura CJ; Campbell WB
Biol Chem; 2013 Sep; 394(9):1205-12. PubMed ID: 23729620
[TBL] [Abstract][Full Text] [Related]
8. Femtomolar bradykinin-induced relaxation of isolated bovine coronary arteries, mediated by endothelium-derived nitric oxide.
Nakamura Y; Kawagoe K; Obi T; Miyamoto A; Ishiguro S; Nishio A
J Vet Pharmacol Ther; 1998 Aug; 21(4):304-8. PubMed ID: 9731953
[TBL] [Abstract][Full Text] [Related]
9. Local production of kinins contributes to the endothelium dependent relaxations evoked by converting enzyme inhibitors in isolated arteries.
Mombouli JV; Illiano S; Vanhoutte PM
Agents Actions Suppl; 1992; 38 ( Pt 3)():186-95. PubMed ID: 1462858
[TBL] [Abstract][Full Text] [Related]
10. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses.
Mombouli JV; Nephtali M; Vanhoutte PM
Hypertension; 1991 Oct; 18(4 Suppl):II22-9. PubMed ID: 1916998
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Li P; Chappell MC; Ferrario CM; Brosnihan KB
Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
[TBL] [Abstract][Full Text] [Related]
12. Kinins mediate kallikrein-induced endothelium-dependent relaxations in isolated canine coronary arteries.
Mombouli JV; Vanhoutte PM
Biochem Biophys Res Commun; 1992 Jun; 185(2):693-7. PubMed ID: 1376991
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.
Nakashima M; Mombouli JV; Taylor AA; Vanhoutte PM
J Clin Invest; 1993 Dec; 92(6):2867-71. PubMed ID: 8254041
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Hecker M; Bara AT; Busse R
Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
[TBL] [Abstract][Full Text] [Related]
15. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
Hecker M; Bara AT; Busse R
J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
[TBL] [Abstract][Full Text] [Related]
16. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin.
Illiano S; Mombouli JV; Nagao T; Vanhoutte PM
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S6-10. PubMed ID: 7527103
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
Cardiovasc Res; 1993 Feb; 27(2):312-7. PubMed ID: 8386065
[TBL] [Abstract][Full Text] [Related]
18. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
Félétou M; Germain M; Teisseire B
Am J Physiol; 1992 Mar; 262(3 Pt 2):H839-45. PubMed ID: 1558194
[TBL] [Abstract][Full Text] [Related]
19. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
